WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014182696) BIORESORBABLE SCAFFOLD FOR NEUROLOGIC DRUG DELIVERY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/182696    International Application No.:    PCT/US2014/036967
Publication Date: 13.11.2014 International Filing Date: 06.05.2014
IPC:
A61L 31/06 (2006.01), A61L 31/14 (2006.01), A61L 31/16 (2006.01)
Applicants: ABBOTT CARDIOVASCULAR SYSTEMS INC. [US/US]; 3200 Lakeside Drive Santa Clara, California 95054 (US)
Inventors: MAZER, Terry B.; (US).
PACETTI, Stephen D.; (US).
LORD, Brenna H.; (US)
Agent: LUPKOWSKI, Mark; Squire Sanders (US) LLP 275 Battery Street, Suite 2600 San Francisco, California 94111 (US)
Priority Data:
13/889,259 07.05.2013 US
Title (EN) BIORESORBABLE SCAFFOLD FOR NEUROLOGIC DRUG DELIVERY
(FR) ÉCHAFAUDAGE BIORÉSORBABLE POUR UNE ADMINISTRATION DE MÉDICAMENT NEUROLOGIQUE
Abstract: front page image
(EN)Bioresorbable scaffolds and methods of treatment with such scaffolds for neurologic disorders including Parkinson's disease, Huntington's disease, Alzheimer's disease, and brain neoplasms are disclosed. The bioresorbable scaffold includes a bioresorbable body and an active agent or drug associated with the body for treating or ameliorating the neurological disorder. The bioresorbable scaffold is implanted in the neurological vasculature brain or brain tissue to provide localized delivery of the drug or active agent. Embodiments of the invention include scaffolds that are partially bioresorbable or completely bioresorbable.
(FR)L'invention concerne des échafaudages biorésorbables et des procédés de traitement de troubles neurologiques comprenant la maladie de Parkinson, la maladie de Huntington, la maladie d'Alzheimer et des néoplasmes cérébraux à l'aide de tels échafaudages. L'échafaudage biorésorbable comprend un corps biorésorbable et un agent actif ou médicament associé au corps pour traiter ou améliorer le trouble neurologique. L'échafaudage biorésorbable est implanté dans le système vasculaire cérébral neurologique ou un tissu cérébral pour fournir une administration localisée du médicament ou agent actif. Des modes de réalisation de l'invention concernent des échafaudages qui sont partiellement biorésorbables ou entièrement biorésorbables.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)